false
Hamburger Menu
Catalog
EGFR Mutant NSCLC Post Osimertinib
EGFR Mutant NSCLC Post Osimertinib
Podcast | English | 31 Min
Create Account
Credit
No Credit Offered
Summary
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a new Virtual Tumor Board on EGFR mutant NSCLC and acquired resistance. Dr. Liu is joined by two thoracic medical oncologists, Dr. Xiuning Le and Dr. Hidehito Horinouchi, both global experts in targeted therapy.
Faculty
Dr. Stephen Liu
Dr. Xiuning Le
Dr. Hidehito Horinouchi
×
EGFR Mutant NSCLC Post Osimertinib Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English